ANTIMICROBIAL RESISTANCE AS A DUAL CRISIS: EVOLUTIONARY BIOLOGY VERSUS GLOBAL HEALTH GOVERNANCE
Keywords:
Antimicrobial resistance, horizontal gene transfer, global health governance, One Health, National Action Plans, mobile genetic elements, Quadripartite alliance, antibiotic stewardship, evolutionary biology, AMR surveillanceAbstract
Antimicrobial resistance (AMR) represents one of the most formidable challenges to modern medicine and public health, simultaneously operating as a crisis of biological evolution and a crisis of international governance. On the biological front, bacteria deploy sophisticated evolutionary mechanisms—including horizontal gene transfer, mobile genetic elements, and biofilm formation—to circumvent antimicrobial agents. On the governance front, the global community struggles with fragmented policy implementation, inadequate funding, and stark disparities across human, animal, and environmental health sectors. This article examines AMR through the lens of this dual crisis, exploring how evolutionary pressures drive resistance emergence while governance failures allow these biological threats to proliferate unchecked. Drawing upon the recently updated Global Action Plan on Antimicrobial Resistance (2026–2036) and recent epidemiological forecasts, we argue that bridging the gap between evolutionary understanding and policy execution is essential for preserving antimicrobial efficacy for future generations.
References
World Health Organization. Draft Updated Global Action Plan on Antimicrobial Resistance. Executive Board 158th Session, Document EB158/18. Geneva: WHO; 2026.
Naghavi M, et al. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. The Lancet. 2024;404:1199–1226.
PMC. Mechanisms of antimicrobial resistance: From genetic evolution to molecular strategies. PMC. 2025;12782932.
International Federation of Pharmaceutical Manufacturers Associations (IFPMA). Statement on Draft Updated Global Action Plan on Antimicrobial Resistance at the 158th Session of the WHO Executive Board. Geneva: IFPMA; 2026.
Musicha P, et al. Time to define One Health approaches to tackling antimicrobial resistance. Nature Communications. 2024;15:8782.
Patel J, et al. Global policy responses to antimicrobial resistance, 2021–22: a systematic governance analysis of 161 countries and territories. The Lancet Infectious Diseases. 2025;26:55–66.
World Bank. Antimicrobial Resistance (AMR): Economic Impact Brief. Washington, DC: World Bank; 2025.
United Nations. Political Declaration of the High-level Meeting on Antimicrobial Resistance. New York: UN; 2024.
Andersson DI, Hughes D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nature Reviews Microbiology. 2010;8:260–271.
Charani E, et al. An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities. The Lancet Global Health. 2023;11:e466–e474.





